In contrast, TLR7 and STING antagonists are promising to be applied to alleviate inflammation, improve the severity of inflammation, reduce cytokine storms caused by viral infections, and treat autoimmune diseases [18,27]. This evidence concerns the gene STING1 and autoimmune disease.